Without a doubt, a VERY large consideration being overlooked.It can be whatever you suggest I suppose. You were very quick to cite the imminent quote I offered to be "misinformation" which is not true even in the least.
You continued on about patients of HRT - something I have a much more intimate familiarity with than I think you give credit as well.
But we'll take a look at that particular quote in context if you want:
(ok, so it actually bleeps out the citation - unsure what to do then...but if you are really interested you can find it before calling anything "misinformation" which is highly inappropriate)
Also, you are citing post-cycle timeframes which has many confounding offerings. In particular, the fact that a good percentage will have spontaneous recovery of HPTA function WITHOUT ANY pharmaceutic agent. Just putting Tamox on board "because it is said to be done" is not appropriate campaign.
Now - post-cyclers versus chronic HRT patients secondary to sheer aging share as many dissimilarities as they do the contrary. So, this is a bit inconsisitent an association to begin with comparing the two.
D_
that particular paragragh is dead on the money.